iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021)
iSpecimen (ISPC) posted quarterly Preferred Stock Liabilities of $2.6 million for Q1 2021, down 76.62% quarter-over-quarter from $11.2 million in Q4 2020.
iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
iSpecimen's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $2.6 million for Q1 2021.
- In Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $2.6 million; the TTM figure through Mar 2021 stood at $2.6 million (changed N/A YoY), while the FY2020 annual figure was $11.2 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q1 2021 stood at $2.6 million, down from $11.2 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $11.2 million in Q4 2020, with the low at $561041.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | iSpecimen | 658,857.59 | -2.16 Mn | 71,599.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.61 Mn |
| Dec 31, 2020 | 11.17 Mn |
| Sep 30, 2020 | 561,041.00 |
| Jun 30, 2020 | 561,041.00 |